Healthcare AI uses a large amount of patient data, often much more than older health technologies. This raises risks about who can access, use, and control the data. Many AI tools are made and run by private companies that may have lots of protected health information (PHI). This can worry patients because these companies might focus more on business goals than on keeping data private.<\/p>\n
One example is the DeepMind partnership with the Royal Free London NHS Foundation Trust, where patient data was shared without enough consent or legal support. This showed problems with sharing data across different places and not giving patients enough control over their own information. In the U.S., similar problems happen when healthcare providers work with technology companies like Microsoft and IBM. The challenge is to balance new ideas with strict privacy rules like those in the Health Insurance Portability and Accountability Act (HIPAA).<\/p>\n
A 2018 survey found that most Americans do not trust sharing health data with tech companies. Only 11% said yes, while 72% trusted doctors. This shows a big gap in trust when it comes to AI used by businesses. Also, only 31% of people felt confident that tech companies keep data safe.<\/p>\n
Old methods to protect patient data often rely on hiding or removing names and other identifiers. But new studies show that AI can often figure out who the data belongs to, even if it is supposed to be anonymous.<\/p>\n
For example, one study about physical activity found that AI could identify 85.6% of adults and 69.8% of children, even though their data was changed. Also, DNA data from genealogy companies could identify about 60% of Americans of European descent by matching with other data. These results show that old privacy methods may not be enough anymore.<\/p>\n
To fix this, U.S. health groups should use better methods. One way is to use synthetic data made by AI. This data looks like real patient information but is not about real people. Using synthetic data helps protect privacy when training and testing AI.<\/p>\n
The laws protecting patient data in the U.S. are complicated and have a hard time keeping up with fast AI changes. HIPAA is the main law that controls how protected health information is used and shared. But HIPAA was not made just for AI, so it has some gaps.<\/p>\n
Other laws, like Europe\u2019s General Data Protection Regulation (GDPR), also affect privacy rules worldwide. GDPR focuses on clear information, consent, and letting people take back permission for data use. These ideas are becoming important for U.S. healthcare managers using AI too.<\/p>\n
Regulators like the U.S. Food and Drug Administration (FDA) have started approving AI medical devices. One example is an AI that finds signs of diabetic eye disease in images. When these devices are approved, extra rules are needed to keep patient data safe.<\/p>\n
AI systems are often \u201cblack boxes,\u201d which means it\u2019s hard to know how they make decisions. This makes it tough for regulators to make sure AI is safe and fair. Healthcare managers need to ask AI companies for clear information and legal responsibility to protect patient data.<\/p>\n
<\/p>\n